Omberacetam
Omberacetam (Noopept)
Evidence & Status
- Preliminary / Experimental
- Preliminary
At a Glance
A small molecule also known as Noopept or GVS-111.
Plain English
Noopept is the alias of omberacetam; this record does not provide general use recommendations.
Overview
Omberacetam (Noopept) is a small molecule. Noopept (omberacetam) is not FDA-approved as a drug in the United States.
Research Summary
The record is limited to its small-molecule identity and does not retain general dosing, route, half-life, product-form, or unsupported safety claims.
Research Areas
- Cognitive enhancement
- Neuroprotection
- BDNF and NGF upregulation
- Memory consolidation
- Mild cognitive impairment
- Post-stroke recovery
Legal Status by Region
- United States
- Noopept (omberacetam) is not FDA-approved as a drug in the United States.
- United Kingdom
- Legal to possess; not approved as medicine
- Australia
- Schedule 4 (Prescription Only Medicine) under the Australian Poisons Standard.
- Canada
- Not approved; research compound